Rhodiola rosea macrocarpa is an herbal medicine with the ability to improve circulation, activate blood circulation and remove blood stasis. Some studies have shown that Rhodiola rosea major can reduce the extent of acute myocardial infarction, lower serum myocardial necrosis markers, and reduce the extent of reperfusion myocardial injury after myocardial infarction. In addition the drug also has the effect of reducing peripheral resistance of blood vessels and coronary resistance, which can increase coronary blood flow and reduce myocardial oxygen consumption, and this drug can also reduce whole blood viscosity, which is clinically used in the adjuvant treatment of stable angina pectoris in coronary artery disease.